Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **accessory gene regulator (Agr) quorum sensing system** is a highly conserved two-component regulatory system in *Staphylococcus aureus* and several other staphylococci, playing a central role in bacterial cell-cell communication and the regulation of virulence. The core Agr operon includes four genes: *agrB*, *agrD*, *agrC*, and *agrA*. AgrD encodes the precursor of the autoinducing peptide (AIP), which is processed and exported by AgrB to the extracellular milieu, where it accumulates in proportion to cell density[2][6][7]. When extracellular AIP reaches a threshold concentration, it binds to and activates AgrC, a membrane-bound histidine kinase. Activated AgrC phosphorylates AgrA, a response regulator that upregulates transcription from two divergent promoters, driving the production of RNAII (components of the Agr system itself) and RNAIII, a regulatory RNA and effector for the system[6][7]. RNAIII modulates multiple virulence genes, promoting expression of toxins and extracellular enzymes while downregulating surface adhesins and colonization factors, thus coordinating the transition from adhesion to invasion[2][6][7]. Agr activity is central to acute infection pathogenesis, and its inhibition is under investigation as a strategy for anti-virulence therapy[7][8]. The Agr system can function independently of RNAIII via AgrA-regulated targets and features regulatory cross-talk with nutrient sensing, oxidative stress, and other signaling pathways[4][5]. Agr-deficient mutants are associated with persistent, biofilm-mediated infection phenotypes, while overactive Agr promotes acute, toxin-mediated pathogenesis[7]. While drugs directly targeting Agr are still experimental, several small molecules and peptides that inhibit AIP signaling or block Agr downstream effects show promise as anti-virulence leads[7][8].
Inhibition of AIP binding to AgrC (histidine kinase sensor)[3][7]; Disruption of RNAIII-mediated gene regulation[7][6]; RNAIII-inhibiting/anti-virulence strategies
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Accessory gene regulator quorum sensing system (Agr (occasionally Agr system or Agr QS system)).